H.R. 2841: FAST Generics Act of 2015

It’s no secret that generic drugs cost less than their name-brand equivalents, for example, using other ibuprofen products besides Advil or other acetaminophen products besides Tylenol, but just how much less they cost may surprise you. According to the Food and Drug Administration (FDA), the average generic costs only 15 to 20 percent as much as its branded counterpart ...

Read the full summary >

What you can do



Jun 18, 2015


Referred to Committee on Jun 18, 2015

This bill was assigned to a congressional committee on June 18, 2015, which will consider it before possibly sending it on to the House or Senate as a whole.


Steve Stivers

Representative for Ohio's 15th congressional district



Read Text »
Last Updated: Jun 18, 2015
Length: 15 pages


1% chance of being enacted according to PredictGov (details)


Jun 18, 2015

This is the first step in the legislative process.

Reported by Committee

Passed House

Passed Senate

Signed by the President

H.R. 2841 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2841 — 114th Congress: FAST Generics Act of 2015.” www.GovTrack.us. 2015. October 28, 2016 <https://www.govtrack.us/congress/bills/114/hr2841>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.